Although various stem cells have successfully been differentiated into IPCs (14), insufficient insulin production by in vitro generated IPCs is a serious obstacle following transplantation of in vitro differentiated cells as treatment of DM in animal models and humans (15). The gene discussed is INS; the disease is diabetes mellitus.